June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Pergolide is comparable to nerve growth factor in recovery after alkali trauma in mouse corneas
Author Affiliations & Notes
  • Xiaohui Zhang
    Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, Oregon, United States
    Ophthalmology, Pharmaron US Lab Services, San Diego, California, United States
  • Kieley Trempy
    Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, Oregon, United States
  • Kaitlyn Hunter
    Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, Oregon, United States
  • Baila Shakaib
    Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, Oregon, United States
  • Lintao Li
    Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, Oregon, United States
  • Cornelia Siegl
    Marinomed Biotech AG, Austria
  • Bonnie Archer
    Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, Oregon, United States
  • Sandeep Kumar
    Ophthalmology, Pharmaron US Lab Services, San Diego, California, United States
  • Glenwood G Gum
    Ophthalmology, Pharmaron US Lab Services, San Diego, California, United States
  • Vatsala Naageshwaran
    Ophthalmology, Pharmaron US Lab Services, San Diego, California, United States
  • Balamurali K Ambati
    Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, Oregon, United States
  • Footnotes
    Commercial Relationships   Xiaohui Zhang None; Kieley Trempy None; Kaitlyn Hunter None; Baila Shakaib None; Lintao Li None; Cornelia Siegl None; Bonnie Archer None; Sandeep Kumar None; Glenwood Gum None; Vatsala Naageshwaran None; Balamurali Ambati None
  • Footnotes
    Support  Fight For Sight grant
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 722. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Xiaohui Zhang, Kieley Trempy, Kaitlyn Hunter, Baila Shakaib, Lintao Li, Cornelia Siegl, Bonnie Archer, Sandeep Kumar, Glenwood G Gum, Vatsala Naageshwaran, Balamurali K Ambati; Pergolide is comparable to nerve growth factor in recovery after alkali trauma in mouse corneas. Invest. Ophthalmol. Vis. Sci. 2023;64(8):722.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Corneal nerve injury is a significant clinical challenge after a chemical burn. Existing treatments are unsatisfactory, for example, nerve growth factor (NGF) is difficult to obtain and very expensive. We previously showed that pergolide upregulates NGF and corneal nerve regeneration in an epithelial scratch mouse model. We hypothesized that topical pergolide can alleviate pain and improve corneal nerve regeneration after chemical injury with alkali burn.

Methods : Alkali (0.75 M NaOH) injury was performed on the cornea of 1 eye per mouse (C57BL/6J, 5 males and 5 females per group). Mice were then given eye drops (10 µl) in the injured eye 3 times daily for 3 weeks; pergolide (600, 300, or 50 µg/ml as solution dissolved in a Marinosolv formulation), vehicle (Marinosolv only), or NGF (100 µg/ml). No treatment (injury only) and naïve (no injury/no treatment) groups did not receive drops. Pain behavior was tested weekly with the wiping test; corneal haze grading and body weight changes were assessed at 3 weeks. Heart and eye globes were collected at 3 weeks and corneal nerve fiber regeneration was assessed with corneal flatmount antibody staining (anti-beta 3 tubulin).

Results : In the wiping test, 300 and 600 µg/ml pergolide and NGF groups showed increased wiping compared to baseline (P<0.05), while pergolide 50 µg/ml and negative control groups did not show any change. This was observed at 3 weeks for males and 2 weeks for females. Haze was reduced in the 600 µg/ml pergolide and NGF groups compared to no treatment (P<0.05). Epithelial nerve fiber density in the 300 and 600 µg/ml pergolide and NGF groups was higher than in negative controls (P<0.05). Pergolide 50 µg/ml was not effective in reducing haze or improving nerve density. No weight loss, cardiac or retinal abnormalities were observed.

Conclusions : Increased wiping behavior aligns with NGF treatment, where patients report pain during reinnervation of the cornea. Improvement in haze highlights the relationship between the corneal nerve, stromal, and epithelial cells, and their countercurrent exchange of factors. Behavioral response discrepancy between sexes without differences in other metrics may be related to pain processing. The results confirm our hypothesis that topical pergolide can improve corneal nerve regeneration in structure and function similar to NGF and supports further investigations.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×